Brain Cancer Treatment; A Systematic Review

AuthorTouba Eslaminejaden
AuthorSeyed Noureddin Nematollahi-Mahanien
AuthorRoghayeh Ershad Sarabien
AuthorMandana Ohadien
AuthorTahereh Eslaminejaden
AuthorMehdi Ansarien
AuthorVida Mirzaieen
OrcidTouba Eslaminejad [0000-0001-5920-1542]en
OrcidSeyed Noureddin Nematollahi-Mahani [0000-0002-4733-1953]en
Issued Date2022-06-30en
AbstractContext: One of the most common aggressive and primary brain tumors is glioma. The majority of diagnoses are referred to high-grade malignant glioblastoma, which carries the worst prognosis. Still, treatment of brain tumors remains a big challenge for clinicians. This study was designed to investigate the efficacy of gene therapy in the treatment of brain cancer. Methods: Studies use genes as a therapeutic agent in brain cancer treatment even alone or in combination with other treatment methods. Full-text papers, which met the inclusion criteria, were independently assessed by two reviewers. Disagreements were resolved by consultation with a third reviewer. Results: Statistical analysis showed that 50% of the papers used a virus, 36% used polymers, and 14% used cells as carriers to transfect the genes as a therapeutic agent in brain tumor models. Data showed that the estimated size of the brain tumor was reduced by using co-treatment of the gene with one of the conventional therapies. Conclusions: According to the results, co-treatment of the gene with conventional therapies could be more effective than the monotherapy methods.en
DOIhttps://doi.org/10.5812/ijcm-121473en
URIhttps://brieflands.com/journals/ijcm/articles/121473en
KeywordBrain Canceren
KeywordGlioblastomaen
KeywordGene Therapyen
KeywordCombination Therapyen
KeywordNeoplasmsen
PublisherBrieflandsen
TitleBrain Cancer Treatment; A Systematic Reviewen
TypeSystematic Reviewen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijcm-15-6-121473.pdf
Size:
152.02 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF